These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 19016151

  • 1. The effect of low-dose cholecalciferol and calcium treatment on posttransplant bone loss in renal transplant patients: a prospective study.
    Sahin G, Yasar NS, Sirmagul B, Bal C, Yalcin AU.
    Ren Fail; 2008; 30(10):992-9. PubMed ID: 19016151
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study.
    Marcén R, Caballero C, Pascual J, Teruel JL, Tenorio M, Ocaña J, Villafruela JJ, Burgos FJ, Fernández AM, Muriel A, Ortuño J.
    Transplantation; 2006 Mar 27; 81(6):826-31. PubMed ID: 16570003
    [Abstract] [Full Text] [Related]

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 27; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K, Brandsaeter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E.
    Scand J Gastroenterol; 2003 Mar 27; 38(3):320-7. PubMed ID: 12737449
    [Abstract] [Full Text] [Related]

  • 7. A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids.
    Wissing KM, Broeders N, Moreno-Reyes R, Gervy C, Stallenberg B, Abramowicz D.
    Transplantation; 2005 Jan 15; 79(1):108-15. PubMed ID: 15714177
    [Abstract] [Full Text] [Related]

  • 8. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
    Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ.
    J Bone Miner Res; 2004 Aug 15; 19(8):1221-30. PubMed ID: 15231008
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neridronate prevents bone loss in patients receiving androgen deprivation therapy for prostate cancer.
    Morabito N, Gaudio A, Lasco A, Catalano A, Atteritano M, Trifiletti A, Anastasi G, Melloni D, Frisina N.
    J Bone Miner Res; 2004 Nov 15; 19(11):1766-70. PubMed ID: 15476575
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
    Reginster JY, Lecart MP, Richy F.
    J Rheumatol Suppl; 2005 Sep 15; 76():21-5. PubMed ID: 16142847
    [Abstract] [Full Text] [Related]

  • 14. Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial.
    Monegal A, Guañabens N, Suárez MJ, Suárez F, Clemente G, García-González M, De la Mata M, Serrano T, Casafont F, Tome S, Barrios C, Navasa M.
    Transpl Int; 2009 Feb 15; 22(2):198-206. PubMed ID: 18796000
    [Abstract] [Full Text] [Related]

  • 15. The effect of calcium and vitamin D3 supplementation on the healing of the proximal humerus fracture: a randomized placebo-controlled study.
    Doetsch AM, Faber J, Lynnerup N, Wätjen I, Bliddal H, Danneskiold-Samsøe B.
    Calcif Tissue Int; 2004 Sep 15; 75(3):183-8. PubMed ID: 15386160
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Alendronate is effective to treat bone loss in renal transplantation recipients.
    Lan G, Peng L, Xie X, Peng F, Wang Y, Yu S.
    Transplant Proc; 2008 Dec 15; 40(10):3496-8. PubMed ID: 19100422
    [Abstract] [Full Text] [Related]

  • 18. Prevention of early loss of bone mineral density after liver transplantation by prostaglandin E1.
    Hommann M, Kämmerer D, Lehmann G, Kornberg A, Küpper B, Daffner W, Wolf G, Settmacher U.
    Transplant Proc; 2007 Mar 15; 39(2):540-3. PubMed ID: 17362777
    [Abstract] [Full Text] [Related]

  • 19. Early bone mineral density loss after renal transplantation and pre-transplant PTH: a prospective study.
    Bubenicek P, Sotornik I, Vitko S, Teplan V.
    Kidney Blood Press Res; 2008 Mar 15; 31(3):196-202. PubMed ID: 18535393
    [Abstract] [Full Text] [Related]

  • 20. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
    Goffin E, Devogelaer JP, Lalaoui A, Depresseux G, De Naeyer P, Squifflet JP, Pirson Y, van Ypersele de Strihou C.
    Transpl Int; 2002 Mar 15; 15(2-3):73-80. PubMed ID: 11935163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.